Latest period
$186.00K
YoY change
—
5Y CAGR
—
Peak year (2025)
$186.00K
Cumulative CapEx
$186.00K
CapEx history chart for Climb Bio (CLYM) from 2019 to 2025
Latest: $186.00K
CapEx history table for Climb Bio (CLYM) from 2019 to 2025
| 2025 | $186.00K | — | +$186.00K | ||
| 2024 | $0.00 | — | $0.00 | ||
| 2023 | $0.00 | — | $0.00 | ||
| 2022 | $0.00 | — | $0.00 | ||
| 2021 | $0.00 | — | $0.00 | ||
| 2020 | $0.00 | — | $0.00 | ||
| 2019 | $0.00 | — | — |
- 2025$186.00K—
- 2024$0.00—
- 2023$0.00—
- 2022$0.00—
- 2021$0.00—
- 2020$0.00—
- 2019$0.00—
CapEx values are taken from Climb Bio's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About CapEx at Climb Bio (CLYM)
According to Climb Bio's latest reported financial statements, the company's current CapEx (TTM) is $186.00K. Capital expenditures (CapEx) are cash outlays for property, plant, and equipment and other long-lived productive assets — reported on the cash flow statement under investing activities. CapEx funds future capacity (factories, data centers, software, machinery), so rising spend can signal investment in growth, while heavy CapEx reduces free cash flow available to shareholders. We display CapEx as a positive amount (the absolute cash outflow); compare with revenue to gauge capital intensity and with total assets for the asset-base context.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, Climb Bio (CLYM) reported CapEx of $186.00K.
$186.00K stands as the all-time-high annual CapEx, posted in 2025, against a low of $0.00 during 2019.
Climb Bio Capital Expenditures by Year
Climb Bio Capital Expenditures 2025: $186.00K
Climb Bio CapEx in 2025 was $186.00K.
Climb Bio Capital Expenditures 2024: $0.00
Climb Bio CapEx in 2024 was $0.00.
Climb Bio Capital Expenditures 2023: $0.00
Climb Bio CapEx in 2023 was $0.00.
Climb Bio Capital Expenditures 2022: $0.00
Climb Bio CapEx in 2022 was $0.00.
Climb Bio Capital Expenditures 2021: $0.00
Climb Bio CapEx in 2021 was $0.00.
See more financial history for Climb Bio (CLYM).
Sector peers by CapEx
Healthcare peers of Climb Bio (CLYM), ranked by their latest CapEx
| $14.05B | |
| $7.84B | |
| $4.83B | |
| $4.11B | |
| $3.62B | |
| $2.81B | |
| $1.86B | |
| $1.21B |
- $14.05B
- $7.84B
- $4.83B
- $4.11B
- $3.62B
- $2.81B
- $1.86B
- $1.21B
Frequently asked questions
Climb Bio (CLYM) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation